CClinicalTrials.gg
Status unknownNCT04299035Updated Mar 6, 2020

ESP Block vs. Traditional Pain Management for ERAS

A Phase 3 interventional study of Erector spinae plane block in Postoperative Pain, sponsored by Soroka University Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-06.

Sponsored by Soroka University Medical Center · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients undergoing thoracotomy, thoracoscopy or other surgical procedures involving the integrity of the chest wall are always in a special point of interest of both surgical and anesthesiological specialities. Most of the patients will describe the pain after thoracic surgery as severe. It might lead to a number of serious complications: respiratory failure due to splinting; inability to clear secretions by effective coughing, with resulting pneumonia; and turning into a chronic pain: the post-thoracotomy pain syndrome.

Traditional pain management in these groups of patients - such as opiate treatment, thoracic epidural analgesia, and non-opioid drugs - may have serious side effects. Large doses of opiates suppress the cough reflex and lead to respiratory depression with subsequent re-intubation and re-ventilation. Thoracic epidural analgesia, though being considered paramount among other analgesic options, requires a significant clinical experience. Still, it might be insufficient for satisfactory pain control and even complicated with pneumothorax, total spinal anaesthesia and inadvertent intravascular injection. Non-steroidal anti-inflammatory drugs (NSAIDs) and Tramadol are weak analgesics inadequate for severe pain control and might be responsible for gastrointestinal bleeding.

We suggest performing erector spinae plane block for intraoperative and postoperative pain management due to the ease of use and better analgesic effect. What remains is hard proof for the clinical efficacy and safety of this block, followed by a demonstration of the uptake of it in the hands of non-regional anaesthetists.

02

Conditions studied

  • Postoperative Pain

Browse trials for

Keywords

  • Postoperative pain
  • Erector spinae plane block
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's planned enrollment of 300 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Soroka University Medical Center is the lead sponsor of 157 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • all consecutive adult patients who undergo thoracic, spinal or abdominal surgery in Soroka Medical Center, and agree to participate in the study, older than 18 years, who meet criteria of ASA physical status I-II-III-IV class.

Exclusion criteria

Exclusion Criteria:

  • Unconscious or mentally incompetent patients or those who refuse to participate in the study.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Thoracic surgery + ESPblock

    Thoracic surgery + ESPblock + standard pain management

    Procedure: Erector spinae plane block

  • Experimental
    Abdominal surgery + ESPblock

    Abdominal surgery + ESPblock + standard pain management

    Procedure: Erector spinae plane block

  • Experimental
    Spinal surgery + ESPblock

    Spinal surgery + ESPblock + standard pain management

    Procedure: Erector spinae plane block

  • No intervention
    Thoracic surgery

    Thoracic surgery + standard pain management

  • No intervention
    Abdominal surgery

    Abdominal surgery + standard pain management

  • No intervention
    Spinal surgery

    Spinal surgery + standard pain management

Interventions

  • ProcedureErector spinae plane block

    Erector spinae plane block

06

What researchers measure

Primary outcomes

  1. Visual Analog Pain Score

    Reported immediate postoperative VAS score, up to 3rd day

    Time frame: 3 days

  2. Total pain med consumption in the PACU

    Total Morphine, NSAIDs and Tramadol amount (mg) in the PACU

    Time frame: 3 hours

  3. Length of stay in the PACU

    Length of stay in postoperative care room

    Time frame: 24 hours

Secondary outcomes

  1. Length of hospital stay

    Length of hospital stay

    Time frame: 30 days

  2. Chronic pain development

    Rate of chronic pain at 3 and 6 months after surgery

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • SorokaUMC
    Beersheba, Israel
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04299035
Lead sponsor
Soroka University Medical Center
Responsible party
Dmitry Natanel MD (Dr., Soroka University Medical Center) — Principal investigator
First posted
Mar 6, 2020
Start date
Mar 5, 2020
Primary completion
Mar 5, 2021 (estimated)
Completion
Sep 5, 2021 (estimated)
Last update
Mar 6, 2020

Study contacts

Dmitry Natanel, MD
Contact
nataneld@bgu.ac.il
+972533360451
Michael Dubilet, MD
Contact
michaeldu@clalit.org.il
Michael Dubilet, MD
principal investigator · Soroka University Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion